I posted ODACs concerns in my post above.
I actually screenshotted the relevant points in the article.
If you don't believe that ODAC said something when I've actually given you the document they wrote that says that thing..... how do we have a serious discussion?
I just don't understand how the simple logic outlined by the fda, ODAC and me is lost on you. It's not downramping to recognise the hurdles a company needs to overcome, it's good investment practices.
MSB Trading 2021 - paradigm shift, page-7844
-
- There are more pages in this discussion • 2,367 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |